Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0909 Fin QTs
BioCentury & Getty Images


Sept. 9 Quick Takes: OncoImmune, Inversago raise B rounds; plus Trillium-Pfizer, Biofourmis, LinkDoc, Singleron, Hrain, InxMed and MilleporeSigma

Sep 10, 2020 | 12:22 AM GMT

OncoImmune raises $56M series B
OncoImmune Inc. raised $56 million in a series B round co-led by HM Capital and an undisclosed investor. Also participating were fellow new investors GBA

Read the full 574 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers